4DMT grants 37,900 RSUs to six new non-executive employees

GlobeNewswire··Read original
1▲0 ▼0Impact / 5
Summary · why it matters

4D Molecular Therapeutics announced that on July 14, 2026, the compensation committee of its board of directors granted 37,900 Restricted Stock Units to six new non-executive employees. The grants were made under the company's 2025 Employment Inducement Award Plan, as amended, in accordance with Nasdaq Rule 5635(c)(4) for equity awards intended to induce new employees to join the company.

Impact on assets 1

Biotech & Genomic Medicine▲ · 1 stocks
© 2026 MarketIVNews